Public Employees Retirement Association of Colorado’s PTC Therapeutics PTCT Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$652K	Hold	7,996	–	–	﹤0.01%	897
2026 Q1	$545K	Hold	7,996	–	–	﹤0.01%	917
2025 Q4	$607K	Hold	7,996	–	–	﹤0.01%	875
2025 Q3	$491K	Sell	7,996 -731	-8%	-$38.1K	﹤0.01%	992
2025 Q2	$426K	Hold	8,727	–	–	﹤0.01%	1050
2025 Q1	$445K	Hold	8,727	–	–	﹤0.01%	991
2024 Q4	$394K	Hold	8,727	–	–	﹤0.01%	1098
2024 Q3	$324K	Hold	8,727	–	–	﹤0.01%	1238
2024 Q2	$267K	Sell	8,727 -473	-5%	-$15.3K	﹤0.01%	1320
2024 Q1	$268K	Hold	9,200	–	–	﹤0.01%	1377
2023 Q4	$254K	Hold	9,200	–	–	﹤0.01%	1438
2023 Q3	$206K	Hold	9,200	–	–	﹤0.01%	1484
2023 Q2	$374K	Hold	9,200	–	–	﹤0.01%	1226
2023 Q1	$446K	Hold	9,200	–	–	﹤0.01%	1098
2022 Q4	$351K	Hold	9,200	–	–	﹤0.01%	1273
2022 Q3	$462K	Hold	9,200	–	–	﹤0.01%	1052
2022 Q2	$369K	Hold	9,200	–	–	﹤0.01%	1229
2022 Q1	$343K	Hold	9,200	–	–	﹤0.01%	1400
2021 Q4	$366K	Hold	9,200	–	–	﹤0.01%	1445
2021 Q3	$342K	Hold	9,200	–	–	﹤0.01%	1480
2021 Q2	$389K	Hold	9,200	–	–	﹤0.01%	1435
2021 Q1	$436K	Hold	9,200	–	–	﹤0.01%	1295
2020 Q4	$561K	Hold	9,200	–	–	﹤0.01%	1021
2020 Q3	$430K	Hold	9,200	–	–	﹤0.01%	1058
2020 Q2	$467K	Hold	9,200	–	–	﹤0.01%	1014
2020 Q1	$410K	Buy	9,200 +1,181	+15%	+$59.5K	﹤0.01%	960
2019 Q4	$385K	Hold	8,019	–	–	﹤0.01%	1208
2019 Q3	$271K	Hold	8,019	–	–	﹤0.01%	1384
2019 Q2	$361K	Hold	8,019	–	–	﹤0.01%	1259
2019 Q1	$302K	Hold	8,019	–	–	﹤0.01%	1327
2018 Q4	$275K	Hold	8,019	–	–	﹤0.01%	1338
2018 Q3	$377K	Hold	8,019	–	–	﹤0.01%	1302
2018 Q2	$270K	Hold	8,019	–	–	﹤0.01%	1476
2018 Q1	$217K	Hold	8,019	–	–	﹤0.01%	1536
2017 Q4	$134K	Hold	8,019	–	–	﹤0.01%	1713
2017 Q3	$160K	Hold	8,019	–	–	﹤0.01%	1610
2017 Q2	$147K	Hold	8,019	–	–	﹤0.01%	1637
2017 Q1	$79K	Hold	8,019	–	–	﹤0.01%	1739
2016 Q4	$87K	Hold	8,019	–	–	﹤0.01%	1745
2016 Q3	$112K	Hold	8,019	–	–	﹤0.01%	1706
2016 Q2	$56K	Hold	8,019	–	–	﹤0.01%	1812
2016 Q1	$52K	Buy	8,019 +3,093	+63%	+$53.7K	﹤0.01%	1817
2015 Q4	$160K	Hold	4,926	–	–	﹤0.01%	1629
2015 Q3	$132K	Hold	4,926	–	–	﹤0.01%	1716
2015 Q2	$237K	Buy	+4,926	New	+$287K	﹤0.01%	1577

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Public Employees Retirement Association of Colorado's PTCT Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 7,996 shares worth $652K. The position accounts for ﹤0.01% of the portfolio, ranked #897.

Public Employees Retirement Association of Colorado first reported a position in PTCT in Q2 2015 and has held it in 45 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Public Employees Retirement Association of Colorado held 7,996 shares of PTC Therapeutics worth $652K as of Q2 2026.
Public Employees Retirement Association of Colorado left its PTC Therapeutics share count unchanged in Q2 2026.
PTC Therapeutics made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #897 holding.
Public Employees Retirement Association of Colorado first reported a position in PTC Therapeutics in Q2 2015 and has held it in 45 quarters since.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.